15 Wiggins Avenue
Toxikon Corporation is an ISO 17025-accredited global contract research organization that conducts safety studies for the medical device and biopharmaceutical industries.
With over 35 years of experience, Toxikon provides testing services to meet FDA/ISO/ICH, OECD, USP and Japan’s MHLW standards. Services include a complete range of PK, TK, ADME and toxicology studies and carcinogenicity, bioavailability, chemical characterization, impurities analysis and synthesis, bioanalytical, efficacy and microbiology assays.
Toxikon operates a 125,000 square foot facility at their headquarters in Bedford, Massachusetts and has additional offices in the U.S., Europe and Asia. Toxikon maintains a subsidiary in Belgium to facilitate growing demands from international clients.